 |
市場調查報告書
商品編碼
1672890
不孕症藥物市場按藥物類型、給藥途徑、性別、分銷管道和地區分類Infertility Drugs Market, By Drug Type, By Route of Administration, By Gender, By Distribution Channel, By Geography |
||||||
2025 年全球生育藥物市場規模估計為 41.8 億美元，預計到 2032 年將達到 66.2 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 6.8%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 41.8億美元 |
| 效能資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025 年至 2032 年複合年成長率 | 6.80% | 2032 年金額預測 | 66.2億美元 |
不孕症是指即使進行規律的無保護性交，也無法自然懷孕。在全球範圍內，不孕症是一個普遍的社會和健康問題。全球生育藥物市場的成長是由男性和女性不孕症盛行率的增加所推動的。壓力水平增加、生活方式改變、肥胖、性行為感染和基因異常等風險因素導致男性和女性不孕症的盛行率不斷上升。輔助生殖技術的進步和生育治療成功率的提高為數百萬陷入困境的夫婦帶來了希望。一些製藥公司提供多種生育藥物，可以治療排卵障礙、荷爾蒙失調和其他不孕症相關問題。
市場動態
全球生育藥物市場的成長受到多種因素的推動，例如不孕症上升、婦科疾病盛行率增加、對不孕症和治療方法的認知不斷提高、醫療保健支出增加、生育藥物方法的技術進步以及政府和其他組織的財政支持。然而，生育藥物成本高、相關併發症和風險、嚴格的法律規範以及一些國家的文化和社會障礙等因素可能會阻礙市場的成長。發展中地區生育藥物診所和 IVF 診所數量的不斷成長可能會提供有利可圖的成長機會。新興國家由於醫療旅遊業的蓬勃發展和優惠的法規政策而具有巨大的成長潛力。
研究的主要特點
本報告對全球不孕症藥物市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，對全球生育藥物市場的主要企業進行了分析。
研究涉及的主要企業包括默克公司、輝凌製藥、麗珠製藥Group Limited、艾伯維公司、默沙東等。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球不孕症藥物市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過全球生育藥物市場分析中使用的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- 一致的機會圖 (COM)
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 市場趨勢
- 監管情景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章 全球生育藥物市場-冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
5. 2020-2032 年全球不孕症藥物市場（按藥物類型分類）（十億美元）
- 介紹
- 克羅米芬檸檬酸鹽
- 性荷爾蒙
- 促性腺激素分泌
- 溴隱亭
- 卡麥角林
- 丙咪嗪
- 來曲唑
- Metformin
6. 2020 年至 2032 年按給藥途徑分類的全球不孕症藥物市場（十億美元）
- 介紹
- 口服
- 腸外
7. 全球生育藥物市場，性別，2020-2032 年（十億美元）
- 介紹
- 男性
- 女士
8. 2020-2032 年全球不孕症藥物市場按分銷管道分類（十億美元）
- 介紹
- 醫院藥房
- 零售藥局
- 網路藥局
9. 2020 年至 2032 年全球不孕症藥物市場（按地區分類）（十億美元）
- 介紹
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第10章 競爭格局
- 公司簡介
- Merck &Co., Inc.
- Ferring Pharmaceuticals
- Pharma Mar, SA
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox BIoTech（Finox AG）
第 11 章 分析師建議
- 興衰
- 一致的機會地圖
第 12 章參考文獻與調查方法
- 參考
- 調查方法
Global Infertility Drugs Market is estimated to be valued at USD 4.18 Bn in 2025 and is expected to reach USD 6.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4.18 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.80% | 2032 Value Projection: | USD 6.62 Bn |
Infertility refers to the inability to conceive a child naturally after a period of regular unprotected sexual intercourse. Globally, infertility is a widely prevalent issue with societal and health implications. Global infertility drugs market growth is driven by increasing incidence of infertility among both men and women. Risk factors like rising stress levels, lifestyle changes, obesity, sexually transmitted diseases, and genetic abnormalities have contributed to growing prevalence of both male and female infertility. Advancements in assisted reproductive technologies and increasing success rates of infertility treatment procedures have provided hope to millions of struggling couples. Several pharmaceutical companies offer a wide range of infertility medications that can treat ovulation disorders, hormonal imbalances, and other fertility-related issues.
Market Dynamics:
Global infertility drugs market growth is driven by factors such as rising infertility rates, increasing prevalence of gynecological disorders, growing awareness about infertility and treatment options, rising healthcare expenditure, technological advancements in fertility treatment procedures, and the financial assistance provided by governments and other organizations. However, factors such as high cost of infertility treatment, complications and risk associated with infertility therapy, stringent regulatory framework, and cultural and social barriers in some nations can hamper the market growth. Growing number of fertility and IVF clinics across developing regions can offer lucrative growth opportunities. Emerging economies offer significant growth potential due to increasing medical tourism and favorable regulations.
Key Features of the Study:
This report provides in-depth analysis of the global infertility drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global infertility drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck, Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbVie Inc., and MSD
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global infertility drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infertility drugs market
Detailed Segmentation-
- By Drug Type
- Clomiphene citrate
- Sex hormones
- Gonadotropins
- Bromocriptine
- Cabergoline
- Imipramine
- Letrozole
- Metformin
- By Gender
- Male
- Female
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Merck & Co., Inc.
- Ferring Pharmaceuticals
- Pharma Mar, S.A.
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox Biotech (Finox AG)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Gender
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Infertility Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Infertility Drugs Market, By Drug Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Clomiphene citrate
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sex hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gonadotropins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bromocriptine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cabergoline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Imipramine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Letrozole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Metformin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Infertility Drugs Market, By Route of Administration, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Infertility Drugs Market, By Gender, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Male
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Infertility Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Infertility Drugs Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Merck & Co., Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ferring Pharmaceuticals
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pharma Mar, S.A.
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox Biotech (Finox AG)
- Merck & Co., Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
